These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 20949455)
1. Diagnostic utility of PAX8 and PAX2 immunohistochemistry in the identification of metastatic Müllerian carcinoma in effusions. Wiseman W; Michael CW; Roh MH Diagn Cytopathol; 2011 Sep; 39(9):651-6. PubMed ID: 20949455 [TBL] [Abstract][Full Text] [Related]
2. PAX2 and PAX8: useful markers for metastatic effusions. Waters L; Crumley S; Truong L; Mody D; Coffey D Acta Cytol; 2014; 58(1):60-6. PubMed ID: 24334997 [TBL] [Abstract][Full Text] [Related]
3. Pax8: a marker for carcinoma of Müllerian origin in serous effusions. Tong GX; Devaraj K; Hamele-Bena D; Yu WM; Turk A; Chen X; Wright JD; Greenebaum E Diagn Cytopathol; 2011 Aug; 39(8):567-74. PubMed ID: 20607683 [TBL] [Abstract][Full Text] [Related]
4. Utility of PAX8 and PAX2 immunohistochemistry in the identification of renal cell carcinoma in diagnostic cytology. Knoepp SM; Kunju LP; Roh MH Diagn Cytopathol; 2012 Aug; 40(8):667-72. PubMed ID: 22807381 [TBL] [Abstract][Full Text] [Related]
5. PAX2 and PAX8 expression in primary and metastatic renal tumors: a comprehensive comparison. Ozcan A; de la Roza G; Ro JY; Shen SS; Truong LD Arch Pathol Lab Med; 2012 Dec; 136(12):1541-51. PubMed ID: 23194047 [TBL] [Abstract][Full Text] [Related]
6. PAX2 and PAX8 expression in primary and metastatic müllerian epithelial tumors: a comprehensive comparison. Ozcan A; Liles N; Coffey D; Shen SS; Truong LD Am J Surg Pathol; 2011 Dec; 35(12):1837-47. PubMed ID: 21989345 [TBL] [Abstract][Full Text] [Related]
7. PAX8 and PAX2 immunostaining facilitates the diagnosis of primary epithelial neoplasms of the male genital tract. Tong GX; Memeo L; Colarossi C; Hamele-Bena D; Magi-Galluzzi C; Zhou M; Lagana SM; Harik L; Oliver-Krasinski JM; Mansukhani M; Falcone L; Hibshoosh H; O'Toole K Am J Surg Pathol; 2011 Oct; 35(10):1473-83. PubMed ID: 21934480 [TBL] [Abstract][Full Text] [Related]
8. [Expression of carbonic anhydrase IX, PAX2 and PAX8 and their association with clinicopathologic characteristics in renal epithelial tumors]. Zhang W; Yu WJ; Xia Y; Liu Y; Liu XL; Zhuang J; Li YJ Zhonghua Bing Li Xue Za Zhi; 2013 Jul; 42(7):442-5. PubMed ID: 24246861 [TBL] [Abstract][Full Text] [Related]
9. A subset of solitary fibrous tumors express nuclear PAX8 and PAX2: a potential diagnostic pitfall. McDaniel AS; Palanisamy N; Smith SC; Robinson DR; Wu YM; Chinnaiyan AM; McHugh JB; Greenson JK; Kunju LP Histol Histopathol; 2016 Feb; 31(2):223-30. PubMed ID: 26404914 [TBL] [Abstract][Full Text] [Related]
10. PAX2(-)/PAX8(-)/inhibin A(+) immunoprofile in hemangioblastoma: A helpful combination in the differential diagnosis with metastatic clear cell renal cell carcinoma to the central nervous system. Carney EM; Banerjee P; Ellis CL; Albadine R; Sharma R; Chaux AM; Burger PC; Netto GJ Am J Surg Pathol; 2011 Feb; 35(2):262-7. PubMed ID: 21263247 [TBL] [Abstract][Full Text] [Related]
11. GATA3: a promising marker for metastatic breast carcinoma in serous effusion specimens. Shield PW; Papadimos DJ; Walsh MD Cancer Cytopathol; 2014 Apr; 122(4):307-12. PubMed ID: 24421220 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of PAX2 and PAX8 expression in salivary gland neoplasms. Butler RT; Alderman MA; Thompson LD; McHugh JB Head Neck Pathol; 2015 Mar; 9(1):47-50. PubMed ID: 24771139 [TBL] [Abstract][Full Text] [Related]
13. A comprehensive analysis of PAX8 expression in human epithelial tumors. Laury AR; Perets R; Piao H; Krane JF; Barletta JA; French C; Chirieac LR; Lis R; Loda M; Hornick JL; Drapkin R; Hirsch MS Am J Surg Pathol; 2011 Jun; 35(6):816-26. PubMed ID: 21552115 [TBL] [Abstract][Full Text] [Related]
15. PAX2 and PAX8 reliably distinguishes ovarian serous tumors from mucinous tumors. Wang M; Ma H; Pan Y; Xiao W; Li J; Yu J; He J Appl Immunohistochem Mol Morphol; 2015 Apr; 23(4):280-7. PubMed ID: 24992169 [TBL] [Abstract][Full Text] [Related]
16. Utility of paired box gene 8 (PAX8) expression in fluid and fine-needle aspiration cytology: an immunohistochemical study of metastatic ovarian serous carcinoma. McKnight R; Cohen C; Siddiqui MT Cancer Cytopathol; 2010 Oct; 118(5):298-302. PubMed ID: 20572292 [TBL] [Abstract][Full Text] [Related]
17. Value of PAX8 and WT1 Immunostaining in Confirming the Ovarian Origin of Metastatic Carcinoma in Serous Effusion Specimens. Zhao L; Guo M; Sneige N; Gong Y Am J Clin Pathol; 2012 Feb; 137(2):304-9. PubMed ID: 22261458 [TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical distinction of renal cell carcinoma from other carcinomas with clear-cell histomorphology: utility of CD10 and CA-125 in addition to PAX-2, PAX-8, RCCma, and adipophilin. Mentrikoski MJ; Wendroth SM; Wick MR Appl Immunohistochem Mol Morphol; 2014 Oct; 22(9):635-41. PubMed ID: 25279712 [TBL] [Abstract][Full Text] [Related]
19. Significant variation of immunohistochemical marker expression in paired primary and metastatic clear cell renal cell carcinomas. Pan Z; Grizzle W; Hameed O Am J Clin Pathol; 2013 Sep; 140(3):410-8. PubMed ID: 23955461 [TBL] [Abstract][Full Text] [Related]
20. Diffuse expression of PAX2 and PAX8 in the cystic epithelium of mixed epithelial stromal tumor, angiomyolipoma with epithelial cysts, and primary renal synovial sarcoma: evidence supporting renal tubular differentiation. Karafin M; Parwani AV; Netto GJ; Illei PB; Epstein JI; Ladanyi M; Argani P Am J Surg Pathol; 2011 Sep; 35(9):1264-73. PubMed ID: 21836481 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]